Matches in Nanopublications for { ?s ?p "[Men carrying the variant A allele at ERCC1 rs2298881 exhibited increased prostate cancer risk with high versus no fonofos use [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.65-5.39; P(interact) = 3.6 � 10(-4); FDR-adjusted P = 0.11].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP381532.RAQrpQpnJWX-EBCMtOjRM9bte_7KM74nFJi45sPLT79vg130_assertion description "[Men carrying the variant A allele at ERCC1 rs2298881 exhibited increased prostate cancer risk with high versus no fonofos use [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.65-5.39; P(interact) = 3.6 � 10(-4); FDR-adjusted P = 0.11].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381532.RAQrpQpnJWX-EBCMtOjRM9bte_7KM74nFJi45sPLT79vg130_provenance.
- NP381571.RAZ5Kg0fgQWXGReByaaFqer2iyjQM4RrSx_lh-gKb4mnY130_assertion description "[Men carrying the variant A allele at ERCC1 rs2298881 exhibited increased prostate cancer risk with high versus no fonofos use [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.65-5.39; P(interact) = 3.6 � 10(-4); FDR-adjusted P = 0.11].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381571.RAZ5Kg0fgQWXGReByaaFqer2iyjQM4RrSx_lh-gKb4mnY130_provenance.
- NP564044.RAKD9CEnG58QUMbW5Ni55ziZ6-OdgwAsoaW7WmlgKduC4130_assertion description "[Men carrying the variant A allele at ERCC1 rs2298881 exhibited increased prostate cancer risk with high versus no fonofos use [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.65-5.39; P(interact) = 3.6 � 10(-4); FDR-adjusted P = 0.11].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564044.RAKD9CEnG58QUMbW5Ni55ziZ6-OdgwAsoaW7WmlgKduC4130_provenance.
- NP621523.RAL0-9vSsPZRnWgBiW8h5G1sALbWPz8xC_eqwu8_ISDyI130_assertion description "[Men carrying the variant A allele at ERCC1 rs2298881 exhibited increased prostate cancer risk with high versus no fonofos use [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.65-5.39; P(interact) = 3.6 � 10(-4); FDR-adjusted P = 0.11].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621523.RAL0-9vSsPZRnWgBiW8h5G1sALbWPz8xC_eqwu8_ISDyI130_provenance.
- NP940399.RAAYtQE-NlzdIai_StmAp3l_0O8jrbpb7AI2ZXq0Bu2Qc130_assertion description "[Men carrying the variant A allele at ERCC1 rs2298881 exhibited increased prostate cancer risk with high versus no fonofos use [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.65-5.39; P(interact) = 3.6 � 10(-4); FDR-adjusted P = 0.11].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940399.RAAYtQE-NlzdIai_StmAp3l_0O8jrbpb7AI2ZXq0Bu2Qc130_provenance.
- NP940398.RAOuJ7d3PXGZshc86_qA1UDMk1O4Fwpxe207Q9eTiUkzA130_assertion description "[Men carrying the variant A allele at ERCC1 rs2298881 exhibited increased prostate cancer risk with high versus no fonofos use [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.65-5.39; P(interact) = 3.6 � 10(-4); FDR-adjusted P = 0.11].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940398.RAOuJ7d3PXGZshc86_qA1UDMk1O4Fwpxe207Q9eTiUkzA130_provenance.